News & Updates

Interspinous diameter seems to be an important factor affecting the difficulty of laparoscopic surgery in patients with mid-low rectal cancer, suggesting that magnetic resonance imaging (MRI) pelvimetry is helpful in gauging the technical difficulty of rectal surgery, a recent study has found.

Adjuvant treatment with metformin does not improve outcomes in most patients with early breast cancer in a phase III study, suggesting that metformin should not be used as a breast cancer treatment in these patients.

In patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC) who respond to first-line induction therapy with panitumumab plus fluorouracil, folinic acid and oxaliplatin (FOLFOX), maintenance panitumumab plus fluorouracil and folinic acid (FU/FA) significantly improves progression-free survival (PFS) vs FU/FA alone, results of the PANAMA trial have shown.

A transseptal needle can be used to recanalize the complete long-segment occlusion of the superior vena cava (SVC) without needing to invest further vascular resources, a recent study has found.

Prophylactic use of the investigational antithrombin siRNA fitusiran significantly reduces bleeding events in people with severe haemophilia compared with on-demand treatment with clotting factor concentrates, according to the phase III ATLAS-A/B trial presented at ASH 2021.

A novel combination of celecoxib and Myrtol for recurrent appendiceal mucinous neoplasma (AMN) with extensive peritoneal dissemination is well tolerated and appears to extend progression-free (PFS) and overall survival (OS) in patients, a recent study has found.